To determine whether the combination therapy can offer protection from diabetes onset, 8–10-week old prediabetic NOD mice were treated with a low-dose (50 μg) one-time administration of anti-CD20 antibody in combination with four weekly injections of proinsulin plasmid. The gene discussed is INS; the disease is diabetes mellitus.